Microbiome Landscape Startup Funding Analytics Report 2021: Startup Activity 2015-2020 & Investment Trends
25 août 2021 10h23 HE
|
Research and Markets
Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "2021 Startup Funding Analytics of the Microbiome Landscape" report has been added to ResearchAndMarkets.com's offering. Like other avenues in the...
Microbiome Landscape Grant Analytics Report 2021: Funding Dropped from $1.9B in 2019 to $1.1B in 2020
24 août 2021 03h23 HE
|
Research and Markets
Dublin, Aug. 24, 2021 (GLOBE NEWSWIRE) -- The "2021 Grant Analytics of the Microbiome Landscape" report has been added to ResearchAndMarkets.com's offering. Several pioneering studies from 2006...
World Microbiome Landscape Clinical Trial Analytics Report 2021: Top 10 Sponsors and Top 10 Companies with Most Ongoing Microbiome Trials
24 août 2021 03h18 HE
|
Research and Markets
Dublin, Aug. 24, 2021 (GLOBE NEWSWIRE) -- The "2021 Clinical Trial Analytics of the Microbiome Landscape" report has been added to ResearchAndMarkets.com's offering. The number of ongoing clinical...
Summit Therapeutics Provides Update on Ri-CoDIFy Trials
11 août 2021 08h00 HE
|
Summit Therapeutics Inc.
Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Based on a thorough review of the design and enrollment status of two ongoing blinded Phase III Ri-CoDIFy trials, Summit Therapeutics...
Global Microbiome Markets 2021-2030: Fecal Microbiota Transplantation (FMT), Drugs, Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers
07 juil. 2021 05h03 HE
|
Research and Markets
Dublin, July 07, 2021 (GLOBE NEWSWIRE) -- The "Microbiome Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's...
Summit Therapeutics to Present Breakthrough Research Updates at the 31st Annual ECCMID Conference, including a Top-Rated ePoster
01 juil. 2021 08h00 HE
|
Summit Therapeutics Inc.
Cambridge, MA, July 01, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (the “Company”) today announced that members of our scientific team will present breakthrough research...
Derm-Biome Pharmaceuticals, Inc. files a US provisional patent for a new generation of natural product-based derivatives and their uses for treating chronic inflammatory skin conditions
29 juin 2021 09h30 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is...
Global Microbiome Markets Report 2021: Market is Expected to Reach $940 Million in 2025 - Forecasts to 2030
17 juin 2021 07h08 HE
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Microbiome Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. Microbiome Global...
Global Microbiome Partnering Deals, Terms and Agreements Analysis 2010-2021
10 juin 2021 06h33 HE
|
Research and Markets
Dublin, June 10, 2021 (GLOBE NEWSWIRE) -- The "Global Microbiome Partnering Terms and Agreements 2010 to 2021" report has been added to ResearchAndMarkets.com's offering. The Global Microbiome...
Derm-Biome Pharmaceuticals, Inc. adds skin disease and microbiome specialists Drs. Youwen Zhou and Andy Sham to Its Newly Created Scientific Advisory Board
02 juin 2021 08h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin health and healthy ageing,...